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Abstract: 
Background: We sought to determine whether assessment of LA function helps to 
identify patients at risk of early deterioration during follow-up with mitral valve 
prolapse (MVP) and mitral regurgitation (MR).   
 
Methods: We retrospectively identified patients with moderate-to-severe MR, but no 
guideline-based indication for surgery, from a dedicated clinical database. Maximal 
and minimal LA volumes (LAVmax; LAVmin) were used to derive the total left atrial 
emptying fraction (TLAEF: LAVmax-LAVmin)/LAVmax x100%). Average peak 
contractile, conduit, and reservoir strain were obtained using 2D speckle-tracking 
imaging.  Study outcome was time to mitral surgery.   
 
Results: 117 patients were included; median follow-up was 18 months.  68 patients 
underwent surgery. ROC curves were used to derive optimal cut-offs for TLAEF 
(>50.7%) and strain (reservoir >28.5%; contractile >12.5%). Using Cox analysis, 
TLAEF, contractile, reservoir and conduit strain were univariate predictors of time-to-
event. After multivariate analysis, TLAEF (HR 2.59, p=0.001), reservoir (HR 3.06, 
p<0.001), and contractile strain (HR 2.01, p=0.022) remained independently 
associated with events, but conduit strain did not. Using Kaplan-Meier curves, event-
free survival was considerably improved in patients with values above the derived 
thresholds. TLAEF: 1-year survival 785% vs. 288%; 3-year survival: 68±6% vs. 
13±5%; both p<0.001.  Reservoir strain: 1-year survival 795% vs. 297%; 3-year 
survival 676% vs. 156% (both p<0.001).  Contractile strain: 1-year survival 805% 
vs. 417%; 3-year survival 696% vs. 246% (both p<0.001).   
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Conclusion: LA function is independently associated with surgery-free survival in 
MVP with moderate-to-severe MR. Quantitative assessment of LA function may have 
clinical utility in guiding early surgical intervention in these patients.   
 
Keywords: mitral valve prolapse; mitral regurgitation; atrial function; prognosis; 
mitral valve surgery 
 
Abbreviations:  
AF  Atrial fibrillation 
BSA  Body surface area 
EF  Ejection fraction 
EROA  Effective regurgitant orifice area 
LA  Left atrium 
LAVmax Maximal LA volume 
LAVmin Minimal LA volume 
LV  Left ventricle 
LVEDV Left ventricular end diastolic volume 
LVESV  Left ventricular end systolic volume 
LVIDd  Left ventricular internal diameter in diastole 
LVIDs  Left ventricular internal diameter in systole 
MR  Mitral regurgitation 
MVP  Mitral valve prolapse 
PA  Pulmonary artery 
TLAEF Total Left Atrial Emptying Fraction 
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Introduction:  
Mitral valve prolapse (MVP) has a prevalence of 2% in the West1, and is the second 
most common valve lesion requiring cardiothoracic surgery2.  Despite this, 
controversy remains as to the optimal timing of surgery3-5.  Severe mitral 
regurgitation with associated cardiovascular symptoms provides a clear mandate for 
intervention6,7.  Furthermore, it is well established that there are a number of clinical 
and echocardiographic features that, if present, should prompt surgical referral even in 
the absence of cardiovascular symptoms. Left ventricular (LV) volume overload, LV 
systolic impairment, the development of elevated pulmonary artery (PA) pressures, 
and the development of atrial fibrillation (AF) are embedded in both American and 
European practice guidelines as indications for surgery in MVP8,9.  Unfortunately, it 
is the case that by the time one or more of these additional features has developed, 
outcomes including patient survival are poorer whether or not surgery is 
performed2,10-16.  As a result, there is a trend toward early surgical referral, 
particularly when the valve lesion in question is deemed to have a high likelihood of 
repair3-5,17.  There is the current unmet clinical need to find parameters that could help 
distinguish those patients in whom clinical deterioration is likely to occur, thereby 
allowing targeting of early surgery, reducing the chances of irreversible complications 
and improving survival. 
 
The left atrium is central to the heart’s adaptive mechanism in chronic MR, and has 
an important functional role.  In mitral valve prolapse, loss of atrial contractile 
function in atrial fibrillation clearly impacts upon prognosis15,16.  We have previously 
examined patients with MR with or without conventional indications for surgical 
intervention and demonstrated that impaired LA functional indices correspond to 
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accepted adverse prognostic findings in MVP18.  The current study expands upon our 
previous work: we wished to determine whether the analysis of LA function could 
help identify individuals without conventional guideline-based indications for surgical 
intervention in whom clinical or echocardiographic deterioration occurs sooner during 
follow-up, thereby potentially allowing identification of the optimal window for 
intervention in MVP.   
 
Methods: 
Study Population:  
Suitable patients were retrospectively identified from a dedicated clinical database, 
which included all individuals assessed in our specialist imaging service between 
August 2009 and February 2013 (Figure 1).  Patient-specific data including clinical 
status and echocardiographic findings were entered into the database 
contemporaneously.  Patients were deemed suitable for inclusion in the current study 
if, at the point of initial review, they demonstrated: 1) the presence of at least 
moderate to severe MR due to MVP or mitral leaflet flail, where MVP was defined as 
the displacement of the tip of one or more segments of the mitral valve by ≥2mm 
relative to the hingepoints of the leaflets, and leaflet flail as the systolic eversion of 
the leaflet tip into the LA; and 2) the absence of a surgical indication according to 
American guidelines8.  All patients were therefore asymptomatic, in sinus rhythm, 
pulmonary artery (PA) pressures were <50mmHg at rest and <60mmHg after 
exertion, had left ventricular (LV) ejection fractions (EF) >60% and LV internal 
diameter in systole (LVIDs) <40mm.  We excluded patients with prior mitral valve 
surgery, more than mild co-existent aortic valve disease, evidence of infective 
endocarditis or a known history of ischaemic heart disease. Using the same database, 
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we have previously published a descriptive analysis of atrial function in patients with 
MR ranging from mild to severe, including a large group with symptoms and other 
guideline-based criteria for surgical intervention18.  Accordingly, the cohorts of the 
two studies substantially overlap, although for the current analysis we extended the 
timeframe for inclusion, focused on a specific subset of patients as outlined above, 
and reported on long-term outcomes.  The institutional review board of Papworth 
Hospital NHS Foundation Trust approved the study and waived the need for signed 
consent for the retrospective analysis.   
 
Image acquisition:  
Transthoracic echocardiography was performed in the lateral decubitus position, 
using an S5-1 transducer and an iE33 imaging platform (Philips; Andover, MA, 
USA).  Data was analyzed offline using commercially available software (Xcelera, 
Philips).  Care was taken to optimize sector width, depth, gain settings and frame 
rates. LV dimensions were recorded from the parasternal long-axis window, and LV 
volumes and EF derived from the apical windows using Simpson’s biplane method. 
Doppler tissue imaging of the mitral annulus was obtained at the inferoseptal and 
anterolateral positions from the apical 4-chamber view. S’ represents average peak 
systolic velocity and E’ average peak diastolic velocity.  In addition, diastolic 
function was described as the ratio of E/E’, where E was measured using pulsed 
Doppler of the mitral inflow from the apical 4-chamber view.  MR severity was 
determined using a multiparametric approach: the effective regurgitant orifice area 
(EROA), estimated using the Proximal Isovelocity Surface Area method, was used for 
the purposes of statistical analysis.  Great care was taken in order to obtain acceptable 
spectral Doppler waveforms of the MR jet from multiple acoustic windows to ensure 
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that in all patients an assessment of EROA was possible. In the case of wall-hugging 
jets however, it is possible that on some occasions the EROA was over- or under-
estimated, but in all patients the overall severity of MR was confirmed by assessment 
of additional features including the vena contracta, and the presence of pulmonary 
venous flow reversal19. PA pressure was estimated through assessment of the 
tricuspid regurgitant jet and right atrial pressure according to American guidelines20.   
 
Atrial function: 
LA parameters were obtained from the apical windows, ensuring the images were 
optimized in order to avoid foreshortening of the atrium.  Maximal and minimal left 
atrial volumes (LAVmax; LAVmin) were determined using Simpson’s biplane 
method combining the 4- and 2-chamber views.  From these, the total left atrial 
emptying fraction (TLAEF: LAVmax-LAVmin)/LAVmax x100%) was derived21. 
Similar to a previous definition22, we recorded three phases of atrial strain: contractile 
(active atrial emptying, corresponding with the P-wave on the surface ECG), conduit 
(passive emptying: after MV opening in early diastole but prior to active emptying), 
and reservoir (representing atrial filling during cardiac systole, and equivalent to the 
sum of contractile and conduit: Figure 2). To acquire this data, standard grey-scale 
images from apical 4- and 2-chamber views were analyzed using semi-automated, 
commercially available software (Cardiac Motion Quantification; Qlab v8.0 and 9.0; 
Philips). The onset of the QRS was used as the zero-reference point, which by 
convention results in all phases of atrial strain being reported as positive values 
(Figure 2)23. Frame rates were in the range of 39-76 fps (median 47; interquartile 
range 40-52).  The LA endocardial-blood border was manually identified by a point 
and click method, allowing the software to generate a region of interest, which was 
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manually optimized to include the LA wall. Visual inspection of the cine image 
ensured that the software was tracking the myocardium appropriately. The atrium was 
divided into 6 segments in each apical view, and the mean of all 12 segments was 
recorded (Figure 2). Analysis of atrial strain and volumes were feasible in the entire 
cohort and no patients were excluded owing to poor image quality.   
 
Clinical assessment and outcomes:  
The evaluation of each patient, and decisions regarding frequency and timing of 
patient follow-up, was independently determined and supervised by the lead 
cardiologist of our specialist valve service, therefore ensuring consistency in the 
clinical approach to the patient cohort.  At each visit, patients underwent 
comprehensive clinical and echocardiographic assessment.  Particular attention was 
paid to establish the symptomatic status of all patients, including the use of exercise 
testing in order to help demonstrate the presence or absence of cardiovascular 
symptoms when appropriate. The clinical and echocardiographic parameters were 
recorded in a dedicated clinical database at the time of initial review.  The primary 
endpoint of the study was cardiac surgery or all-cause mortality, which was recorded 
for all patients up to January 2017.  Outcomes were identified through review of the 
dedicated clinical database and individual patient clinical records. Deaths were also 
identified using the UK Health and Social Care Information Service to ensure none 
were missed.  Patients who were offered surgery but declined were considered an 
event for the purposes of the analysis, and any patient whose care was transferred to 
another institution after our initial assessment but before mitral valve surgery was 
required, had final follow-up recorded as the point of their last review in our service.  
The ultimate decision to proceed to surgery was the responsibility of the lead 
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cardiologist, often after discussion in a multi-disciplinary team environment, which 
included two surgeons with a specialist interest in mitral valve surgery and a second 
cardiologist with an expertise in percutaneous valve intervention.  All decisions were 
based upon clinical and echocardiographic findings in accordance with American 
guidelines8. Atrial functional indices, including TLAEF and strain, were analyzed by 
an individual who was not involved in clinical decision-making.  The supervising 
cardiologist was blinded to the results of atrial functional analysis.  
 
Statistical analysis:  
Data was analyzed using SPSS v19.0 (SPSS Inc., Chicago, IL, USA).  Continuous 
variables are summarized as mean ± standard deviation (SD) or median (inter-quartile 
range (IQR)) where appropriate.  To determine whether atrial function was associated 
with the need for mitral valve surgery during, Cox proportional hazard models were 
employed.  Clinical, echocardiographic and LA functional indices that were 
significant or borderline (p<0.1) on univariate analysis were entered into a 
multivariate model of time-to-event with cardiac surgery as the dependent variable.  
To avoid colinearity between volumetric and strain markers of LA function, separate 
models were constructed for each parameter in turn.  Atrial functional indices were 
entered into the multivariate models as dichotomous variables.  The optimal cut-off 
values for atrial parameters for use in the multivariate models were determined from 
receiver-operator characteristic curves as the value with optimal sensitivity and 
specificity as defined by the Youden index.  Sequential Cox models were employed to 
determine the incremental prognostic usefulness of atrial function indices over 
standard clinical and echocardiographic data.  Kaplan-Meier estimator curves were 
constructed for atrial indices to estimate surgery-free survival, and were compared 
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using the log-rank test. Measurement reproducibility was determined by selecting 10 
patients at random, and the measurements repeated by the original and a second 
operator whilst blinded to the original results.  The within-subject coefficient of 
variation and 95% limits of agreement were calculated using the Bland-Altman 
method.  Statistical significance was defined as p<0.05.   
 
Results:  
A total of 117 patients were identified (85 male, median age 61 (50-71) years).  
Baseline characteristics are in Table 1. We were able to follow all patients for the 
duration of the study. The longest follow-up was 81 months (median 18 (7-43) 
months).  During follow-up, 68 patients required mitral valve surgery.  Three patients 
died: one had undergone successful mitral valve repair 2 years prior to death, and the 
remaining two deaths occurred in patients who had been offered mitral valve surgery 
but declined.  Therefore all events included in the outcome analysis were mitral valve 
surgery.  In all patients, surgery was recommended on the basis of their mitral valve 
disease alone, and not as part of any other surgery.  Indications for surgical referral 
were: isolated cardiovascular symptoms (n=40); LV dysfunction (n=11, of whom 8 
were asymptomatic); raised PA pressures (n=13, of whom 9 were asymptomatic); and 
new onset atrial fibrillation (n=4).  Of the 117 patients, 89 were included in our earlier 
descriptive study as mentioned previously.   
 
On univariate analysis, TLAEF, reservoir, contractile and conduit strain were all 
strongly associated with the dependent variable (Table 2).  In addition, LVIDd, LA 
volume, PA pressure, EROA and E/E’ were all significantly associated with the need 
for cardiac surgery during follow-up on univariate analysis (Table 2).  After 
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multivariate analysis, TLAEF, contractile and reservoir strain remained independent 
predictors of surgery-free survival but conduit strain did not (Table 3): TLAEF 
(Hazard ratio (HR) 2.59, 95% CI 1.44-4.65; p=0.001), reservoir (HR 3.06, 95% CI 
1.66-5.61; p<0.001), and contractile strain (HR 2.01, 95% CI 1.11-3.65; p=0.022).  
 
To estimate surgery-free survival, Kaplan-Meier estimator curves were constructed 
using LA function indices.  Optimal cut-offs for the atrial function indices were: 
TLAEF 50.7% (area under the ROC curve (AUC) 0.728; sensitivity 54%; specificity 
88%); reservoir strain 28.5% (AUC 0.733; sensitivity 56%; specificity 88%); and 
contractile strain 12.5% (AUC 0.763; sensitivity 66%; specificity 80%).  Patients with 
TLAEF above the threshold value were afforded superior 1- and 3-year event-free 
survival (1-year survival: 785% vs. 288%; 3-year survival: 68±6% vs. 13±5%; 
p<0.001; Figure 3).  Similarly, patients in whom reservoir or contractile strain were 
above the derived cut-off values were noted to have superior outcomes.  For reservoir 
strain, the difference in observed 1- and 3-year survival was as follows: 1-year 
survival 795% vs. 297%; 3-year survival 676% vs. 156% (both p<0.001; Figure 
4).  For contractile strain, the difference in 1-year survival was 805% vs. 417%; 
and for 3-year survival was 696% vs. 246% (both p<0.001; Figure 5).   
 
Finally, we repeated the analysis, specifically focusing only on those patients with an 
EROA of 0.4cm2. This was in order to establish the value of atrial functional indices 
in patients with clearly severe MR. TLAEF, reservoir and contractile strain all 
remained independently associated with the combined outcome. Similarly, those 
patients in whom atrial functional indices were above the derived cut-offs 
demonstrated superior 1- and 3-year event-free survival: TLAEF HR 2.85 (95% CI 
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1.42-5.75), p=0.003; 1-year event-free survival 599% vs. 308%; 3-year event-free 
survival 419% vs. 75%.  Contractile strain: HR 2.07 (95% CI 1.06-4.07), p=0.034; 
1 year survival 5811% vs. 378%; 3-year event-free survival 3811% vs. 166%.  
Reservoir strain: HR 3.28 (95% CI 1.62-6.66), p=0.001; 1 year survival 619% vs. 
298%; 3-year event-free survival 399% vs. 105%.  
 
Sequential Cox models were used to determine the additional value obtained from 
TLAEF and strain indices when combined with standard echocardiographic 
indications for surgery (LVIDs, EF, PA pressure, LA volume and EROA). The 
baseline model (2= 41.4) was improved with the addition of either TLAEF (2 56.9; 
p<0.001), or combined reservoir and contractile strain (2 59.2; p=0.001).  
 
Measurement variability (coefficient of variation and 95% limits of agreement) for 
intra-observer differences were: TLAEF 4.6% and ±3.7%; reservoir 4.9% and ±2.2%; 
contractile 5.7% and ±1.0%; conduit 8.5% and ±2.3%. Inter-observer differences 
were: TLAEF 7.8% and ±6.4%; reservoir 7.7% and ±3.3%; contractile 8.0% and 
±1.6%; conduit 8.9 and ±2.1%.   
 
 
Discussion: 
This retrospective study demonstrates that left atrial function parameters are 
associated with poorer outcomes in patients with moderate to severe mitral 
regurgitation but no conventional indication for surgical intervention. We propose that 
the routine analysis of atrial function may be of clinical utility in identifying patients 
in whom early surgery for MVP with mitral regurgitation may be warranted.   
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The LA is an essential aspect of the heart’s adaptive mechanism to mitral 
regurgitation. When MR develops acutely, the inability of the LA to absorb the 
sudden increase in blood volume results in pulmonary edema24,25.  In MVP, MR 
usually worsens gradually, allowing the LA to undergo morphological adaptations.  
Eventually, these adaptations become disadvantageous, and excessive LA 
enlargement is associated with increased mortality in patients with MVP and severe 
MR26,27.   
 
The left atrium additionally has an important functional role. In healthy individuals 
the contribution of LA function to cardiac output is relatively modest, but in 
cardiovascular disease and even normal ageing, the importance of LA function is 
more pronounced28-31.  By convention, the LA has three phases during which it 
demonstrates specific functional capabilities: reservoir, representing LA expansion 
during ventricular systole; conduit, occurring after opening of the mitral valve during 
which there is passive atrial emptying; and contractile, which corresponds with the p-
wave on the surface ECG, representing active atrial emptying just prior to mitral 
valve closure32.  Prior work using volumetric methods has demonstrated that the 
contractile phase of LA function is impaired following mitral valve repair, suggesting 
that pre-operative atrial dysfunction is masked by the presence of MR33,34.  More 
recently, speckle-tracking techniques have been used to examine atrial function, and 
has subsequently proved useful in a number of clinical scenarios, including predicting 
the development of atrial fibrillation during cardiac surgery or in the presence of 
mitral valve disease22,35,36.  Alterations in LA strain may reflect histopathological 
changes occurring within the atrium: in a group of patients who underwent LA biopsy 
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at the time of surgery for MVP, the extent of fibrosis corresponded to reductions in 
atrial function derived using speckle-tracking imaging37.  We have previously 
examined atrial function in a cross-section of patients with MVP and MR.  Marked 
reductions in reservoir and contractile strain particularly were observed in patients 
with established cardiovascular symptoms, elevations of PA pressures, or adverse 
alterations in LV size or function18.  
 
Yang et al have examined the prognostic value of LA deformation in patients with 
asymptomatic severe mitral regurgitation38.  They noted that impaired atrial strain 
predicted the development of heart failure symptoms or cardiovascular death, 
although a significant proportion of the study cohort had an established indication for 
surgery at enrolment, including the presence of AF, elevated PA pressures or LV 
enlargement, and as such this work does not reflect the management of these patients 
in American guidelines.  Debonnaire and colleagues have demonstrated that LA 
reservoir strain <24% is associated with poorer survival in patients after mitral valve 
surgery, although again this was a heterogenous group of patients, many of whom had 
existing surgical indications at baseline39.  There appear to be consistencies with the 
current study: whereas reservoir strain of <24% is associated with adverse survival, 
our proposed cut-off of 28.5% is linked to the need for earlier cardiac surgery, but 
with excellent long-term outcomes. Additionally, both studies confirm the value of 
reservoir strain, re-iterating that both active and passive aspects of LA function are 
important in the hearts adaptation to chronic MR.  This may be because reservoir 
strain reflects the ability of the LA to absorb the regurgitant jet, the overall burden of 
LA scar, or atrial adaptation to increased filling pressures18,37.   
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Conventional guidelines for intervention in MVP with MR include the development 
of cardiovascular symptoms, the presence of elevated pulmonary pressures, or the 
development of left ventricular dysfunction8.  Unfortunately, it is usually the case that 
when these criteria have been met, patient outcomes are poorer irrespective of 
whether surgery is performed6,12,13,40. Consequently, there is a current trend toward 
early surgical referral, particularly if the valve in question has a high likelihood of 
repair3,17.  We believe the current study may provide value in this regard.  We have 
shown that contractile and reservoir strain display subtle early alterations that precede 
the development of clinical or echocardiographic features that mandate intervention 
and are independently associated with time to cardiac surgery. Combining derived 
cut-offs for reservoir and contractile strain of 28.5% and 12.5% respectively was able 
to identify patients in whom indications for surgery occurred much sooner during 
follow-up. We therefore propose that assessment of atrial strain may be useful to help 
target individuals for early surgical intervention, or at the very least closer clinical and 
echocardiographic surveillance, but at the same time avoiding unnecessary 
intervention in those in whom a watchful waiting approach may be suitable.   
 
 
Limitations: 
This study represents retrospective analysis of patients in a single-center with the 
inherent possibility of referral bias, and therefore requires confirmation in multiple 
centers through a prospective trial. Atrial strain indices may vary according to 
imaging platform and software systems, and therefore current results may not be 
applicable to all manufacturers.  Although in our specialist service great care was 
taken to elicit the presence of cardiac symptoms, including the use of exercise testing, 
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as with any retrospective analysis, it is possible (although we feel it unlikely) that 
some patients were erroneously labeled as being asymptomatic.  During the course of 
this study, the American guidelines for surgical intervention in mitral valve disease 
have been updated. One substantial change has been the removal of exercise-induced 
elevation of PA pressures as a Class IIa indication, but as no patients in our study 
were operated on for this reason alone our results are unaffected. In the 2017 update, 
progressive change in LV size or function has been included as a Class IIa indication, 
although no clear guidance as to the rapidity or magnitude of change that should 
prompt intervention is provided.  Therefore we believe that this addition does not 
detract from the potential clinical utility the analysis of atrial function may provide in 
this scenario.   
 
Conclusion: 
The left atrium is central to the heart’s adaptation to chronic mitral regurgitation.  In a 
cohort of patients with MVP and at least moderate MR, derived cut-offs for atrial 
functional indices was associated with shorter surgery-free survival, and provided 
incremental prognostic information to standard clinical and echocardiographic 
parameters.  Quantitative analysis of atrial function may be of clinical utility in the 
assessment of patients with MVP, for early identification of the optimal surgical 
window.  
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Figure Legends: 
 
Figure 1: A consort of the patients included in the study.   
 
Figure 2: An example of atrial strain analysis. Top left and right panels depict an 
example of atrial strain obtained from the apical 4-chamber and 2-chamber windows 
respectfully. The lower panel gives an example strain-time curve (in this case 
obtained from the apical 2-chamber view).  The atrium is divided into 6 segments 
(colored lines), with the average strain represented by the dotted white line. The onset 
of the QRS is marked and is used as the zero reference for our strain analysis.  The 
three phases of atrial strain are annotated, and the onset of contractile strain can be 
seen to correspond to the p-wave on the ECG (labeled).  
 
Figure 3:  Survival according to LA function.  Kaplan-Meier curve of surgery-free 
survival according to stratification by TLAEF.    
 
Figure 4: Survival according to LA strain.  Kaplan-Meier curve of surgery-free 
survival according to stratification by reservoir strain.  
 
Figure 5: Survival according to LA strain.  Kaplan-Meier curve of surgery-free 
survival according to stratification by contractile strain.  
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Table 1: Baseline characteristics 
 
Variables All (n=117) Event (n=68) No event (n=49) 
Clinical    
Male gender, n (%) 85 (73) 48 (71) 37 (76) 
Age, years 61 (50-71) 62 (50-71) 56 (49-73) 
Range 16-86 16-86 19-82 
Body Surface Area, 
kg/m2 
1.9 (1.8-2.1) 1.9 (1.8-2.1) 1.9 (1.7-2.1) 
Echocardiography    
LVIDd, mm 54±6 56±6 53±6 
LVIDs, mm 33 (29-36) 33 (28-37) 32 (29-35) 
LVEDV, ml 130±36 133±40 125±28 
Indexed, ml/m2 67±17 69±19 66±14 
LVESV, ml 43±14 44±14 42±12 
Indexed, ml/m2 22±6 23±7 22±6 
EF, % 66 (62-71) 66 (62-71) 65 (62-71) 
Avg S’ (cm/s) 9.5 (8.5-10.5) 9.5 (8.4-11.0) 9.5 (8.4-10.0) 
Avg E’ (cm/s) 10.1±2.8 10.2±2.8 9.9±2.8 
Avg E/E’ 9.6 (7.8-13.1) 8.0 (7.0-10.0) 11.0 (9.1-14.1) 
LA volume, ml 104 (74-122) 117 (90-146) 80 (60-105) 
Indexed, ml/m2 52 (38-66) 60 (49-70) 40 (32-53) 
PA pressure (mmHg) 25 (20-37) 32 (20-42)  20 (20-30) 
Mitral valve detail    
EROA, cm2 0.4 (0.2-0.5) 0.4 (0.4-0.6) 0.3 (0.2-0.4) 
Severe MR 
(EROA0.40cm2), n (%) 
62 (53) 52 (76) 10 (20) 
Flail segment, n (%) 22 (19) 18 (26) 4 (8) 
LA functional indices    
TLAEF, % 52±10 50±10 56±8 
Reservoir strain, % 31 (24-38) 28 (21-35) 35 (30-42) 
Contractile strain, % 13 (9-17) 10 (7-15) 15 (13-18) 
Conduit strain, % 17 (14-22) 17 (13-21) 18 (15-23) 
 
 24 
LVIDd=left ventricular internal diameter diastole; LVIDs=left ventricular internal diameter systole; LVEDV=left 
ventricular end-diastolic volume; LVESV=left ventricular end-systolic volume; EF=ejection fraction; Avg 
S=average systolic velocity mitral annular tissue Doppler imaging; LA=left atrial; PA=pulmonary artery; 
EROA=effective regurgitant orifice area; TLAEF=total left atrial emptying fraction 
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Table 2: Univariate associations of time to event during follow-up 
 
 
 Hazard ratio 95% Confidence interval P-value 
Clinical    
Male gender 0.952 0.565-1.606 0.855 
Age 1.010 0.995-1.026 0.184 
Echocardiography    
LVIDd 1.748 1.176-2.598 0.006 
LVIDs 1.233 0.773-1.965 0.380 
LVEDV 1.002 0.996-1.009 0.495 
LVESV 1.001 0.984-1.019 0.903 
EF 1.012 0.968-1.057 0.602 
Avg S’  1.059 0.940-1.192 0.346 
Avg E’ 1.020 0.930-1.118 0.678 
Avg E/E’ 1.080 1.032-1.130 0.001 
LA volume 1.014 1.008-1.020 <0.001 
PA pressure 1.059 1.034-1.085 <0.001 
EROA 2.290 1.540-3.404 <0.001 
Atrial functional indices    
TLAEF  
Continuous 
Optimal cut-off (50.7%) 
 
1.070 
3.867 
 
1.044-1.096 
2.373-6.302 
 
<0.001 
Reservoir 
Continuous 
Optimal cut-off (28.5%) 
 
1.064 
4.078 
 
1.036-1.092 
2.500-6.652 
 
<0.001 
Contractile 
Continuous 
Optimal cut-off (12.5%) 
 
1.149 
3.114 
 
1.089-1.212 
1.851-5.238 
 
<0.001 
Conduit 
Continuous 
Optimal cut-off (15.5%) 
 
1.046 
1.43 
 
1.008-1.087 
0.89-2.32 
 
0.018 
 
Abbreviations as previously 
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Table 3: Multivariate Cox proportional hazard models for prediction of need for 
cardiac surgery 
 
 
Model 1 with TLAEF 
 
Variables 
 
Hazard ratio (95% CI) 
 
P-value 
LVIDd 1.22 (0.74-2.02) 0.439 
E/E’ 1.03 (0.97-1.09) 0.416 
LA volume 1.00 (0.99-1.01) 0.777 
PAP 1.03 (1.01-1.06) 0.017 
EROA 2.06 (1.23-3.46) 0.006 
TLAEF 2.59 (1.44-4.65) 0.001 
 
 
Model 2 with reservoir strain 
 
Variables Hazard ratio (95% CI) P-value 
LVIDd 1.42 (0.86-2.35) 0.169 
E/E’ 1.03 (0.97-1.10) 0.283 
LA volume 1.00 (0.99-1.01) 0.759 
PAP 1.03 (1.00-1.06) 0.036 
EROA 2.11 (1.27-3.51) 0.004 
Reservoir strain 3.06 (1.66-5.61) <0.001 
 
 
Model 3 with contractile strain 
 
Variables Hazard ratio (95% CI) P-value 
LVIDd 1.22 (0.73-2.04) 0.454 
E/E’ 1.03 (0.97-1.10) 0.287 
LA volume 1.00 (0.99-1.01) 0.476 
PAP 1.03 (1.00-1.06) 0.038 
EROA 1.97 (1.16-3.35) 0.012 
Contractile strain 2.01 (1.11-3.65) 0.022 
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Model 4 with conduit strain 
 
 
Variables Hazard ratio (95% CI) P-value 
LVIDd 1.26 (0.76-2.10) 0.365 
E/E’ 1.04 (0.99-1.11) 0.139 
LA volume 1.00 (1.00-1.01) 0.293 
PAP 1.04 (1.01-1.07) 0.007 
EROA 2.06 (1.23-3.46) 0.006 
Conduit strain 1.24 (0.72-2.15) 0.444 
 
 
Abbreviations as previously 
 
 
 
 
 
 
 
 
